Lexeo Therapeutics
(NASDAQ) LXEO
Lexeo Therapeutics Financials at a Glance
Market Cap
$384.64M
Revenue (TTM)
$0.00
Net Income (TTM)
$104.97M
EPS (TTM)
$-2.70
P/E Ratio
-1.95
Dividend
$0.00
Beta (Volatility)
1.95 (High)
Dividend
$0.00
Beta (Volatility)
1.95 (High)
Price
$5.27
Volume
34,494
Open
$5.39
Price
$5.27
Volume
34,494
Open
$5.39
Previous Close
$5.27
Daily Range
$5.01 - $5.42
52-Week Range
$1.45 - $10.99
Dividend
$0.00
Beta (Volatility)
1.95 (High)
Price
$5.27
Volume
34,494
Open
$5.39
Previous Close
$5.27
Daily Range
$5.01 - $5.42
52-Week Range
$1.45 - $10.99
LXEO News
LXEO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lexeo Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
72
CEO
R. Nolan Townsend, MBA
Website
www.lexeotx.comHeadquarters
New York City, 10010, US
LXEO Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-81%
Return on Capital
-90%
Return on Assets
-73%
Earnings Yield
-51.28%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$384.64M
Shares Outstanding
72.99M
Volume
34.49K
Short Interest
0.00%
Avg. Volume
996.50K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$105.77M
EBITDA
$96.19M
Operating Cash Flow
$81.15M
Capital Expenditure
$481.00K
Free Cash Flow
$81.63M
Cash & ST Invst.
$121.52M
Total Debt
$9.92M
Lexeo Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$530.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$384.64M
N/A
Market Cap/Employee
$5.13M
N/A
Employees
75
N/A
Net Income
$20.28M
+31.2%
EBITDA
$19.73M
+31.8%
Quarterly Fundamentals
Net Cash
$32.54M
-77.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$5.74M
-25.6%
Short Term Debt
$2.71M
+1.2%
Return on Assets
-72.97%
N/A
Return on Invested Capital
-89.69%
N/A
Free Cash Flow
$29.84M
-66.8%
Operating Cash Flow
$29.55M
-65.9%